ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
BioNexus Gene Lab Corporation

BioNexus Gene Lab Corporation (BGLC)

2,88
0,01
(0,35%)
Geschlossen 26 April 10:00PM
2,76
-0,12
(-4,17%)
Nach Börsenschluss: 1:59AM

Professionelle Tools für Privatanleger.

Premium

Wichtige Statistiken und Details

Current Price
2,88
Gebot
2,75
Fragen
2,95
Volumen
14.050
2,75 Tagesbereich 2,92
0,2105 52-Wochen-Bereich 3,49
Marktkapitalisierung
Handelsende
2,87
Handelsbeginn
2,92
Letzte Trade
15
@
2.85
Letzter Handelszeitpunkt
Finanzvolumen
US$ 39.854
VWAP
2,8366
Durchschnittliches Volumen (3 Mio.)
1.160.010
Ausgegebene Aktien
17.967.663
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-19,62
Gewinn pro Aktie (EPS)
-0,15
Erlöse
10,26M
Nettogewinn
-2,63M

Über BioNexus Gene Lab Corporation

BioNexus Gene Lab Corp is an emerging molecular diagnostics company focused on the application of functional genomics to enable early diagnosis and personalized health management. It focuses on developing and marketing safe, effective, and non-invasive blood tests for the early detection of diseases... BioNexus Gene Lab Corp is an emerging molecular diagnostics company focused on the application of functional genomics to enable early diagnosis and personalized health management. It focuses on developing and marketing safe, effective, and non-invasive blood tests for the early detection of diseases. The company's non-invasive blood tests analyze changes in ribonucleic acid (or RNA) to detect the potentiality of 11 different diseases. These diseases include eight cancers (nasopharyngeal, lung, liver, stomach, breast, cervical, prostate, and colon), two bowel diseases (colitis and Crohn), and osteoarthritis. Mehr anzeigen

Sektor
Medical Laboratories
Branche
Medical Laboratories
Hauptsitz
Sheridan, Wyoming, USA
Gegründet
-
BioNexus Gene Lab Corporation is listed in the Medical Laboratories sector of the NASDAQ with ticker BGLC. The last closing price for BioNexus Gene Lab was US$2,87. Over the last year, BioNexus Gene Lab shares have traded in a share price range of US$ 0,2105 to US$ 3,49.

BioNexus Gene Lab currently has 17.967.663 shares in issue. The market capitalisation of BioNexus Gene Lab is US$51,57 million. BioNexus Gene Lab has a price to earnings ratio (PE ratio) of -19.62.

BGLC Neueste Nachrichten

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
10.238.679245283022.652.992.4701579422.81108505CS
42.62461027.642913080.25543.490.226219881292.38431898CS
122.458582.4644549760.4223.490.226211600101.47770688CS
262.5099678.1680626860.37013.490.210526101440.61845437CS
522.2552360.9475032010.62483.490.210514161190.60062884CS
156-0.62-17.71428571433.59.490.210517079901.07796174CS
260-0.62-17.71428571433.59.490.210517079901.07796174CS

BGLC - Frequently Asked Questions (FAQ)

What is the current BioNexus Gene Lab share price?
The current share price of BioNexus Gene Lab is US$ 2,88
How many BioNexus Gene Lab shares are in issue?
BioNexus Gene Lab has 17.967.663 shares in issue
What is the market cap of BioNexus Gene Lab?
The market capitalisation of BioNexus Gene Lab is USD 51,57M
What is the 1 year trading range for BioNexus Gene Lab share price?
BioNexus Gene Lab has traded in the range of US$ 0,2105 to US$ 3,49 during the past year
What is the PE ratio of BioNexus Gene Lab?
The price to earnings ratio of BioNexus Gene Lab is -19,62
What is the cash to sales ratio of BioNexus Gene Lab?
The cash to sales ratio of BioNexus Gene Lab is 5,03
What is the reporting currency for BioNexus Gene Lab?
BioNexus Gene Lab reports financial results in USD
What is the latest annual turnover for BioNexus Gene Lab?
The latest annual turnover of BioNexus Gene Lab is USD 10,26M
What is the latest annual profit for BioNexus Gene Lab?
The latest annual profit of BioNexus Gene Lab is USD -2,63M
What is the registered address of BioNexus Gene Lab?
The registered address for BioNexus Gene Lab is 1309 COFFEEN AVENUE STE 1200, SHERIDAN, WYOMING, 82801
What is the BioNexus Gene Lab website address?
The website address for BioNexus Gene Lab is www.bionexusgenelab.com
Which industry sector does BioNexus Gene Lab operate in?
BioNexus Gene Lab operates in the MEDICAL LABORATORIES sector
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
WWWW International Inc
US$ 0,395
(167,62%)
223,58M
OMEXOdyssey Marine Exploration Inc
US$ 1,4979
(75,79%)
285,65M
RTCBaijiayun Group Ltd
US$ 0,3244
(74,88%)
263,23M
GREEGreenidge Generation Holdings Inc
US$ 1,3197
(53,92%)
5,84M
SXTCChina SXT Pharmaceuticals Inc
US$ 2,28
(44,30%)
38,04M
CGTLCreative Global Technology Holdings Ltd
US$ 1,5197
(-75,09%)
3,88M
TOIIWOncology Institute Inc
US$ 0,1015
(-40,22%)
156,14k
COEPCoeptis Therapeutics Holdings Inc
US$ 7,70
(-38,25%)
716,99k
INTSIntesity Therapeutics Inc
US$ 0,56
(-37,78%)
3,21M
SMMTSummit Therapeutics Inc
US$ 23,47
(-36,05%)
24,67M
GNLNGreenlane Holdings Inc
US$ 0,012699
(-15,34%)
355,22M
AGMHAGM Group Holdings Inc
US$ 0,0477
(22,31%)
340,91M
OMEXOdyssey Marine Exploration Inc
US$ 1,4979
(75,79%)
285,65M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
US$ 10,455
(19,62%)
266,95M
RTCBaijiayun Group Ltd
US$ 0,3244
(74,88%)
263,23M
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

Delayed Upgrade Clock